Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil

BACKGROUND: Despite high cure rates, treatment-related mortality in children with acute lymphoblastic leukemia (ALL) remains significant. About 4% of patients die during remission induction therapy and approximately two-thirds of treatment-related deaths are due to infectious complications. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufrayer, Mauro Cesar, Rechenmacher, Ciliana, Meneses, Clarice Franco, Monteiro, Yasmine Massaro Carneiro, Carlesse, Fabianne Altruda de Moraes Costa, Motta, Fabrizio, Daudt, Liane Esteves, Michalowski, Mariana Bohns
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978458/
https://www.ncbi.nlm.nih.gov/pubmed/36750202
http://dx.doi.org/10.1016/j.bjid.2023.102745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978458/
https://www.ncbi.nlm.nih.gov/pubmed/36750202
http://dx.doi.org/10.1016/j.bjid.2023.102745

Ejemplares similares